You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hematology malignancy

Showing 1 - 25 of 1,962
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy Trial in Copenhagen (HM-PRO)

Active, not recruiting
  • Hematologic Malignancy
  • HM-PRO
  • Copenhagen, Denmark
    Dept. of Hematology
Jun 14, 2022

Hematologic Malignancy Trial in Boston (PATH-C)

Not yet recruiting
  • Hematologic Malignancy
  • PATH-C
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Nov 23, 2023

Hematologic Malignancy, Stem Cell Transplant Complications Trial in Beijing (Beijing protocol)

Recruiting
  • Hematologic Malignancy
  • Stem Cell Transplant Complications
  • Beijing protocol
  • Beijing, Beijing, China
    Deparment of Hematology, Peking University People's Hospital
Jun 19, 2023

Hematologic Malignancy, Hematologic Tumors, Hematologic Diseases Trial in Nanjing, Suzhou, Tianjin (Flow Cytometry)

Not yet recruiting
  • Hematologic Malignancy
  • +2 more
  • Flow Cytometry
  • Nanjing, Jiangsu, China
  • +2 more
Apr 17, 2023

Prospective Cohort With Hemopathy in Languedoc-Roussillon

Recruiting
  • Hematologic Malignancy
  • hematologic malignancy
  • Montpellier, France
    Hematology department - UHMontpellier Saint éloi
Dec 31, 2021

Hematologic Malignancy Trial in Tuebingen,, Tuebingen (CD45RA depleted donor lymphocyte infusion (DLI))

Recruiting
  • Hematologic Malignancy
  • CD45RA depleted donor lymphocyte infusion (DLI)
  • Tuebingen,, Germany
  • +1 more
Jul 13, 2023

Hematological Malignancy Trial in Roskilde (Taste-test, Standard care)

Enrolling by invitation
  • Hematological Malignancy
  • Taste-test
  • Standard care
  • Roskilde, Denmark
    Department of Hematology
May 5, 2022

Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy Trial in United States (Emavusertib, ibrutinib)

Recruiting
  • Relapsed Hematologic Malignancy
  • Refractory Hematologic Malignancy
  • Phoenix, Arizona
  • +10 more
Feb 1, 2023

CB-Long-Term Safety Study (CB-LTSS)

Enrolling by invitation
  • Lymphoma, Non-Hodgkin
  • +7 more
  • Allogeneic CAR-T therapy
  • Irvine, California
  • +3 more
Nov 18, 2022

Covid19, Hematologic Malignancy, Vaccine Response Impaired Trial in Quimper (Patients with hemopathy)

Recruiting
  • Covid19
  • +2 more
  • Patients with hemopathy
  • Quimper, France
    Centre Hospitalier de Quimper Cornouaille
Apr 20, 2021

Non-Hodgkin's B-cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Leukemia Trial in Worldwide (MT-3724

Terminated
Has Results
  • Non-Hodgkin's B-cell Lymphoma
  • +5 more
  • MT-3724 Phase 1
  • MT-3724 Phase 2
  • Tucson, Arizona
  • +40 more
Jul 18, 2022

Haematologic Disease, Haematological Malignancy Trial in Italy (clinical data and sample collection)

Recruiting
  • Haematologic Disease
  • Haematological Malignancy
  • clinical data and sample collection
  • Meldola, FC, Italy
  • +4 more
Feb 25, 2021

Acute Myelogenous Leukemia, Multiple Myeloma, MDS Trial in Greece, Spain, United States (This is a non-interventional study)

Completed
  • Acute Myelogenous Leukemia
  • +6 more
  • This is a non-interventional study
  • Bakersfield, California
  • +19 more
Apr 4, 2022

P53 Mutation, Myeloid Malignancy, MDS Trial in Shanghai (Decitabine, Arsenic Trioxide)

Recruiting
  • P53 Mutation
  • +3 more
  • Shanghai, Shanghai, China
    Hematological department, Shanghai Institute of Hematology, Ruij
Apr 20, 2021

MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular

Recruiting
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • +8 more
    • Boston, Massachusetts
    • +6 more
    Apr 14, 2022

    Advanced Unresectable or Metastatic Solid Malignancy Trial in United States (Entrectinib, Inavolisib, Alectinib)

    Recruiting
    • Advanced Unresectable or Metastatic Solid Malignancy
    • Birmingham, Alabama
    • +50 more
    Aug 10, 2022

    Oral Complications in Hematological Malignancies

    Not yet recruiting
    • Hematologic Malignancy
      • Assiut, Egypt
        Assiut university
      Mar 6, 2023

      Screening for Hematology Branch Protocols

      Enrolling by invitation
      • Hematologic Disease and Disorders
      • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 28, 2023

        Research Data and Samples From Patients Who Experience

        Recruiting
        • Malignancy
        • Biospecimen Collection
        • Medical Chart Review
        • Anchorage, Alaska
        • +518 more
        Sep 25, 2022

        Acute Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndrome Trial in Guangzhou (HSCT from MSD, HSCT from MUD, HSCT from

        Completed
        • Acute Leukemia
        • +2 more
        • HSCT from MSD
        • +6 more
        • Guangzhou, Guangdong, China
          Department of Hematology,Nanfang Hospital, Southern Medical Univ
        Mar 3, 2020

        Haematological Malignancy Trial in Rouen (Enteric capsule)

        Unknown status
        • Haematological Malignancy
        • Enteric capsule
        • Rouen, France
          Centre Henri Becquerel
        Nov 20, 2019

        AMS Intervention for Early Adaptation of Empirical Antibiotic

        Completed
        • Neutropenia
          • Nice, France
            University Hospital of Nice
          Mar 29, 2023

          Cancer, Bone Marrow Tumors, Anxiety Trial in United States (PRISM (Promoting Resilience in Stress Management))

          Active, not recruiting
          • Cancer
          • +7 more
          • PRISM (Promoting Resilience in Stress Management)
          • Birmingham, Alabama
          • +4 more
          Nov 29, 2022

          Oral Mucositis Trial (Bocaliner, Benzydamine)

          Enrolling by invitation
          • Oral Mucositis
          • Yerevan, Armenia
            Hematology Center after Prof. R. Yeolyan
          Dec 20, 2022

          Tumor, Plasma Cell, Lymphoma Trial in Toulouse (Comprehensive Geriatric Assessment)

          Recruiting
          • Neoplasm, Plasma Cell
          • Lymphoma
          • Comprehensive Geriatric Assessment
          • Toulouse, France
            University Hospital Toulouse
          Oct 12, 2022